Live·Open questions in longevity research
All news
Longevity research

Aging may result from the continued action of the mechanism that stops body growth: biologists propose testing this by restoring controlled growth in aged tissues

13 November 2026· 261113005

Aging may result from the continued action of the mechanism that stops body growth: biologists propose testing this by restoring controlled growth in aged tissues

On November 12, a Royal Society journal published a review by Idálio de Jesus Viegas and João Pedro de Magalhães of the University of Birmingham. The authors revisit a hypothesis proposed by zoologist George Bidder.

In 1932, Bidder wrote in the British Medical Journal that aging was “a late consequence of the mechanism that determines species-specific body size.” He called this mechanism a “regulator”: it continues to act after growth stops, with aging as a byproduct. Bidder, who studied growth in flatfish, believed that fish that grow throughout life do not age. Gerontologist Alex Comfort tested this in guppies: females grow throughout life, yet their mortality increased with age, as it does in small mammals.

Viegas and de Magalhães reformulated Bidder’s hypothesis in terms of tissue turnover. In many tissues, cells and proteins are broken down and replaced; tissue grows as long as production exceeds breakdown. Growth inhibition reduces the proportion of dividing cells until production matches breakdown. The authors propose that inhibition continues beyond this point: growth becomes negative, breakdown exceeds production, and the tissue shrinks. The same idea was tested in mice in 2010 at the US National Institutes of Health: many age-related changes in gene activity begin as growth slows in young animals.

If growth inhibition continues, adult tissues should lose cells and mass. In aging humans, the thymus, brain, and muscles atrophy, and protein synthesis declines. In mice, increasing signaling by VEGF, a growth factor that promotes blood vessel growth, prevented capillary loss and extended lifespan. Almost completely switching off the Myc gene, which stimulates cell division, had the opposite effect, producing signs of premature aging. The mice nevertheless lived longer because cancer was three to four times less common.

Interventions that slow growth yet extend lifespan challenge the model: calorie restriction, the drug rapamycin, and reduced growth hormone signaling. The authors respond that the hypothesis is better suited to explaining differences between species. Within a species, larger individuals often have shorter lifespans than smaller ones, and these interventions may reproduce the signaling patterns of smaller individuals. Across species, larger animals tend to live longer and generally have lower levels of IGF-1, a mediator of growth hormone action. The authors suggest that other mechanisms determine body size in larger species, while the growth-inhibitory signal is weaker or begins later: growth continues for longer, and aging is delayed.

Aging researcher Mikhail Blagosklonny’s hyperfunction hypothesis attributes aging to excessive cell growth after the body stops growing and appears to contradict Bidder’s model. The authors allow that both mechanisms could operate in parallel and explain different features of aging. They consider growth inhibition just one possible cause of aging.

The authors propose the following test:

“If growth restriction causes some forms of age-related decline, then stimulating controlled growth should prevent this loss of function.”

The inhibitory signals themselves remain largely unknown, so the authors suggest starting with known growth promoters: Myc, the growth factors FGF and VEGF, and telomerase, which extends chromosome ends. They propose assessing the results through tissue function and epigenetic clocks, which indicate biological age. Cancer could be a side effect: according to de Magalhães’s hypothesis, tissues lose their capacity to regenerate during development partly as a defense against tumors.

Originally published on Telegram by Ukhvat NewsView on Telegram
Sources
#growth-inhibition#tissue-atrophy#bidder-hypothesis#vegf#myc#aging